80 FR 55879 - Information Collection: Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations Other Than Conventional Residences Receiving Such Patients

NUCLEAR REGULATORY COMMISSION

Federal Register Volume 80, Issue 180 (September 17, 2015)

The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a proposed collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ``Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than Conventional Residences Receiving Such Patients.''

[Federal Register Volume 80, Number 180 (Thursday, September 17, 2015)]
[Notices]
[Pages 55879-55880]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-23367]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2015-0102]


Information Collection: Destinations of Released Patients 
Following Treatment with Iodine-131 and Estimation of Doses to Members 
of the Public at Locations Other Than Conventional Residences Receiving 
Such Patients

AGENCY: Nuclear Regulatory Commission.

ACTION: Proposed information collection: request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a proposed collection of information to the Office of 
Management and Budget (OMB) for review. The information collection is 
entitled, ``Destinations of Released Patients Following Treatment with 
Iodine-131 and Estimation of Doses to Members of the Public at 
Locations other than Conventional Residences Receiving Such Patients.''

DATES: Submit comments by October 19, 2015.

ADDRESSES: Submit comments directly to OMB reviewer at: Vlad Dorjets, 
Desk Officer, Office of Information and Regulatory Affairs (3150-XXXX), 
NEOB-10202, Office of Management and Budget, Washington, DC 20503;

[[Page 55880]]

telephone: 202-395-7315, email: [email protected].

FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2015-0102 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2015-0102. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2015-0102 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. A 
copy of the collection of information and related instructions may be 
obtained without charge by accessing ADAMS Accession No. ML15209A593. 
The supporting statement available in ADAMS under Accession No. 
ML15209A605.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting NRC's Clearance Officer, Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
[email protected].

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not want to be publicly 
disclosed in your comment submission. All comment submissions are 
posted at http://www.regulations.gov and entered into ADAMS. Comment 
submissions are not routinely edited to remove identifying or contact 
information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. Chapter 35), the NRC recently submitted a proposed collection of 
information to OMB for review entitled, ``Destinations of Released 
Patients Following Treatment with Iodine-131 and Estimation of Doses to 
Members of the Public at Locations other than Conventional Residences 
Receiving Such Patients.'' The NRC hereby informs potential responses 
that an agency may not conduct or sponsor, and that a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on Tuesday, May 19, 2015 (80 FR 
28715).
    1. The title of the information collection: Destinations of 
Released Patients Following Treatment with Iodine-131 and Estimation of 
Doses to Members of the Public at Locations other than Conventional 
Residences Receiving Such Patients.
    2. OMB approval number: An OMB control number has not yet been 
assigned to this proposed information collection.
    3. Type of submission: New.
    4. The form number, if applicable: N/A.
    5. How often the collection is required or requested: One-time.
    6. Who will be required or asked to respond: Institutions that 
treat thyroid cancer patients with I-131 and the thyroid cancer 
patients who have been treated.
    7. The estimated number of annual responses: 5,175 (175 for 
treating institutions and 5000 for individuals).
    8. The estimated number of annual respondents: 5,175.
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 1,675 (175 hours for 
treating institution and 1500 hours for individuals).
    10. Abstract: Although most patients return to their home after 
receiving diagnostic or therapeutic of Iodine-131, some patients 
released by the licensee may stay at another location (such as a hotel) 
for a few days. However, the extent of this practice is unclear. The 
same uncertainty exists regarding patients returning to nursing homes 
and other institutional settings. Therefore, one of the main objectives 
of this study is to obtain reliable statistical data that provides good 
estimates of the prevalence of these practices. The second objective is 
to determine, by measurements, the external and internal doses received 
by members of the general public at hotels, nursing homes, or other 
institutional settings that receive treated patients immediately after 
their release.

    Dated at Rockville, Maryland, this 14th day of September, 2015.

    For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-23367 Filed 9-16-15; 8:45 am]
BILLING CODE 7590-01-P